v3.26.1
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 3 Months Ended 12 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Dec. 31, 2025
Operating activities:      
Net loss $ (6,468) $ (24,982)  
Loss from discontinued operations, net of tax 0 21,172  
Adjustments to reconcile net loss to cash (used for) provided by operating activities:      
Depreciation and amortization 61,742 42,902  
Share-based compensation expense 3,090 4,421  
Deferred income tax expense (benefit) 2,571 (4,395)  
Changes in operating lease right-of-use assets and lease liabilities 122 827  
Gain from sale and dispositions of patient service equipment (55,509) (5,353)  
Changes in operating assets and liabilities:      
Accounts receivable, net (7,796) 4,745  
Inventories, net 9,150 (6,319)  
Accounts payable 8,775 16,124  
Net change in other assets and liabilities (69,174) (18,065)  
Other, net 3,420 401  
Cash used for operating activities from discontinued operations 0 (66,544)  
Cash used for operating activities (50,077) (35,066)  
Investing activities:      
Additions to patient service equipment ($41,343 and $44,484) and other fixed assets (41,646) (45,793)  
Proceeds from sale of patient service equipment 96,415 16,884  
Additions to computer software (844) (2,329)  
Other, net 0 (410)  
Cash used for investing activities from discontinued operations 0 (16,552)  
Cash provided by (used for) investing activities 53,925 (48,200)  
Financing activities:      
Borrowings under Revolving Credit Facility 269,100 776,984  
Repayments under Revolving Credit Facility (217,600) (679,484)  
Repurchase of common stock 0 (1,503)  
Other, net (416) (146)  
Cash used for financing activities from discontinued operations 0 (3,073)  
Cash provided by financing activities 51,084 92,778  
Effect of exchange rate changes on cash and cash equivalents (41) 542  
Net increase in cash and cash equivalents 54,891 10,054  
Cash and cash equivalents at beginning of period 281,989 49,382 $ 49,382
Cash and cash equivalents at end of period 336,880 59,436 $ 281,989
Supplemental disclosure of cash flow information:      
Income taxes paid, net 20,042 125  
Interest paid 29,446 27,487  
Noncash investing activity:      
Unpaid purchases of patient service equipment and other fixed assets at end of period $ 71,997 $ 81,085